Medical Device News Magazine

Research Park at Florida Atlantic University® Based FloSpine Successfully Implants First Ti-Largo 3D Printed Cervical Cage

Recently Cleared Device Patient-Centrically Designed, Enhances Osseointegration and Biocompatibility

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Together with FloSpine, the Research Park at Florida Atlantic University® is pleased to announce the successful implantation of the Ti-Largo 3D Printed Cervical Cage, a groundbreaking advancement in the field of spinal surgery. The Ti-Largo Cervical Cage is designed to seamlessly complement the already FDA-cleared Panama Anterior Cervical Plate, creating a comprehensive solution for cervical spine procedures.

The Ti-Largo 3D Printed Cervical Cage represents a significant milestone in FloSpine’s commitment to developing cutting-edge spinal solutions that improve patient outcomes and enhance the capabilities of surgeons. This revolutionary cervical cage leverages 3D printing technology to deliver a highly customizable, patient-specific implant that enables minimally invasive cervical spine surgery.

Key features of the Ti-Largo 3D Printed Cervical Cage include:

  • Patient-Centric Design: Each Ti-Largo cervical cage is designed to meet the unique anatomical needs of the patient. This personalized approach ensures a precise fit and optimized spinal stability.
  • Enhanced Biocompatibility: The Ti-Largo cage is 3D printed from a high-grade titanium alloy known for its excellent biocompatibility, corrosion resistance, and strength. This material minimizes the risk of adverse reactions and offers long-term durability.
  • Minimally Invasive Surgery: The Ti-Largo implant is designed for minimally invasive cervical spine surgery, reducing tissue disruption, post-operative pain, and recovery time for patients.
  • Optimized Osseointegration: The porous structure of the Ti-Largo cage facilitates bone ingrowth, promoting fusion and long-term stability.

The FDA clearance of the Ti-Largo 3D Printed Cervical Cage underscores FloSpine’s commitment to adhering to the highest regulatory standards and its dedication to delivering innovative solutions to patients and healthcare providers.

Inaugurating this momentous occasion, Dr. John Afshar, a renowned spinal surgeon at Palm Beach Neuroscience Institute successfully implanted the Ti-Largo 3D Printed Cervical Cage in the first patients earlier this month. Dr. Afshar shared, “The Ti-Largo cervical cage represents a major leap forward in cervical spine surgery. Its patient-specific design and 3D printing technology have the potential to revolutionize the way we approach these procedures, offering greater precision and improved outcomes for our patients.”

The Ti-Largo 3D Printed Cervical Cage couples with FloSpine’s Panama Anterior Cervical Plate, which received FDA clearance in 2021. This combination provides surgeons with a comprehensive solution for anterior cervical spine surgery, ensuring stability, alignment, and long-term fusion.

FloSpine CEO, Peter Harris, expressed pride and optimism for the future, stating, “The successful implantations of the Ti-Largo 3D Printed Cervical Cage, in conjunction with the Panama Anterior Cervical Plate, are a testament to the dedication and ingenuity of our team. We are excited about the positive impact this innovation will have on patients’ lives.”

FloSpine is actively collaborating with medical professionals, hospitals, and healthcare institutions to introduce the Ti-Largo Cervical Cage and Panama Anterior Cervical Plate to a broader patient population. This next generation technology has the potential to transform the landscape of cervical spine surgery, providing new hope and improved outcomes for those suffering from cervical spine conditions.

FloSpine has benefited from the support and assistance of the Global Ventures second-stage company incubator as it has grown. Dialogue and interaction with Florida Atlantic University’s faculty spurred innovation in the material design, executed by graduates of FAU’s College of Engineering and Computer Science.

“FloSpine’s growth and development demonstrates that Global Ventures is effective at growing companies in Palm Beach County with local residents and resources. The benefits are felt across the community and over the years,” commented Andrew S. Duffell, president of the Research Park at FAU. “We congratulate the innovation and focus of the FloSpine team.”

FloSpine expects to move from the Global Ventures incubator into the Research Park itself in the coming months, to accommodate its long-term growth in close proximity to its support network.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”